Cargando…
RSL3 Drives Ferroptosis through NF-κB Pathway Activation and GPX4 Depletion in Glioblastoma
Glioblastoma, the most aggressive form of malignant glioma, is very difficult to treat because of its aggressively invasive nature and high recurrence rates. RAS-selective lethal 3 (RSL3), a well-known inhibitor of glutathione peroxidase 4 (GPX4), could effectively induce oxidative cell death in gli...
Autores principales: | Li, Shengbiao, He, Yuping, Chen, Kexin, Sun, Jiaojiao, Zhang, Lulu, He, Yaxin, Yu, Hong, Li, Qiuhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720588/ https://www.ncbi.nlm.nih.gov/pubmed/34987700 http://dx.doi.org/10.1155/2021/2915019 |
Ejemplares similares
-
RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer
por: Sui, Xinbing, et al.
Publicado: (2018) -
The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1
por: Cheff, Dorian M., et al.
Publicado: (2023) -
GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis
por: Kim, Joo-Won, et al.
Publicado: (2023) -
Copper-dependent autophagic degradation of GPX4 drives ferroptosis
por: Xue, Qian, et al.
Publicado: (2023) -
Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
por: Yi, Renxin, et al.
Publicado: (2020)